senateStanding
Judiciary Committee
- Referred To
← Back to federal legislationOfficial committee record ↗ Official committee record ↗ Congress.gov ↗ Congress.gov ↗
H.R. 27Passed House
HALT Fentanyl Act
Introduced: Jan 3, 2025
Latest action date: Feb 10, 2025
Your view
Current stage
Passed House
The full action history records passage in the House.
Introduced
Jan 3, 2025
Latest action
Feb 10, 2025
Recorded roll calls
0
Civixly topics
What this legislation is about
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
Official CRS policy area
Crime and Law Enforcement
View 5 official legislative subjects
Administrative law and regulatory proceduresDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrationsResearch administration and funding
Bill Summary
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).
Additionally, the bill establishes a new, alternative registration process for certain schedule I research.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
Committee activity
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Official committee record ↗
houseStanding
Judiciary Committee
- Referred To
houseStanding
Energy and Commerce Committee
- Referred To
Amendments
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
View amendments2 amendments
H.Amdt. 5houseNot agreed toFeb 6, 2025
An amendment numbered 2 printed in Part B of House Report 119-2 to delay the enactment of this bill until the Secretary of Health and Human Services and the Attorney General each certify that the bill will lead to a reduction in overdose deaths.
Latest action: On agreeing to the Trahan amendment (A002) Failed by the Yeas and Nays: 182 - 226 (Roll no. 32).
H.Amdt. 4houseAgreed toFeb 6, 2025
Pursuant to the provisions of H. Res. 93, the amendment printed in part A of House Report 119-2 is considered as adopted.
Latest action: On agreeing to the Rules amendment (A001) Agreed to without objection.
Checked against Congress.gov Sep 13, 2026.
Action timeline
Newest action first. Action language comes from the official Congress.gov record.
View full action timeline15 actions
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
IntroReferralSenateMotion to reconsider laid on the table Agreed to without objection.
FloorHouse floor actionsOn passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)
FloorHouse floor actionsPassed/agreed to in House: On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)
FloorLibrary of CongressConsidered as unfinished business. (consideration: CR H533-535)
FloorHouse floor actionsPOSTPONED PROCEEDINGS - At the conclusion of debate on the Trahan amendment No. 2, the Chair put the question on agreeing to the amendment and by voice vote, announced that the noes prevailed. Mrs. Trahan demanded the yeas and nays and the Chair postponed further proceeding until a time to be announced.
FloorHouse floor actionsDEBATE - Pursuant to the provisions of H. Res. 93, the House proceeded with 10 minutes of debate on the Trahan amendment No. 2.
FloorHouse floor actionsDEBATE - The House proceeded with one hour of debate on H.R. 27.
FloorHouse floor actionsRule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.
FloorHouse floor actionsConsidered under the provisions of rule H. Res. 93. (consideration: CR H520-533)
FloorHouse floor actionsRule H. Res. 93 passed House.
FloorHouse floor actionsRules Committee Resolution H. Res. 93 Reported to House. Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.
FloorHouse floor actionsReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferralHouse floor actionsIntroduced in House
IntroReferralLibrary of CongressIntroduced in House
IntroReferralLibrary of Congress
Roll-call votes
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
Discussion
0 comments
Sign in to join the discussion.Comments are publicly visible.
Loading comments...